fbpx
Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
POULTRY PORK
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Poultry Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Sponsored By Zoetis

.

Zoetis offering research funds for parasitic disease in poultry, other species

Zoetis is offering grants of up to $150,000 to find new approaches for controlling parasites in poultry and other species.

Proposals for poultry research, the company added, should focus on new approaches to control coccidiosis, the most economically important disease to poultry producers worldwide.

Through a grant-awards program, Zoetis will award a minimum of $25,000 and maximum of $150,000 to support each selected grant proposal. More than one grant may be awarded. The application deadline is Feb. 28, 2018.

“Through this grant program, we aim to energize investigation into anti-parasitic therapeutics research and advance science in this area of high need in animal health,” said Debra Woods, PhD, research director, head of parasitology global therapeutics research, Zoetis.

Zoetis is also seeking proposals that could extend the duration of efficacy of active ingredients using persistent formulations.

Grant applications (download) will be reviewed by a Zoetis committee composed of leaders from across divisions and disciplines. Candidates will be notified of the committee’s decision by March 31, 2018.

 

 





tags: ,
RELATED NEWS
  • IBD V877 vaccine can break through maternal antibodies

    A live infectious bursal disease (IBD) vaccine based on the V877 strain can override maternal antibodies, doesn’t revert to virulence and has limited interactions with other live vaccines.

  • Live E. coli, Salmonella vaccines remained effective when used together in challenge study

    Administration of a modified-live Escherichia coli vaccine along with a live Salmonella vaccine does not appear to affect the efficacy of either, indicate the results of a recent challenge study.[1] For the study, the researchers divided specific-pathogen-free layer...

  • Study shows value of E. coli vaccine in chickens

    A live Escherichia coli vaccine provided a high level of protection to chickens challenged with the same E. coli strain as well as cross-protection against a different strain in a recent study conducted in the Netherlands.

  • Antibiotic-free production: Tips for making it work

    After following trends in antibiotic-free production over the past several years, Tim Cummings, DVM, has identified a few production practices worth incorporating.




You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.